Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Real-World Practice Patterns of Patient Management in the Peri-CAR T-Cell Therapy Setting for Patients with Mantle Cell Lymphoma: An International Survey on Behalf of the EBMT Lymphoma Working Party

Gloria Iacoboni, Pere Barba, Irma Khvedelidze, Maud Ngoya, Paolo Corradini, Pierre Sesques, Marion Subklewe, Maria Gomes Da Silva, Gilles Crochet, Jarosław Dybko, Izaskun Zeberio, Alejandro Martín García-Sancho, Tom van Meerten, Maeve O'Reilly, Bertram Glass, Ana Maria Sureda Balari, Peter Dreger, Olivier Hermine, Ali Bazarbachi

Blood (2024) 144 (Supplement 1): 3656.

https://doi.org/10.1182/blood-2024-205389

Published: 2024

Journal Articles

Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study

Blood (2022) 140 (14): 1635–1649.

https://doi.org/10.1182/blood.2022015506

Published: 2022

Includes: Supplemental data

Journal Articles

Analysis of Risk Factors Determining Incidence and Outcome of Infections in Children and Adults after Hematopoietic Cell Transplantation

Blood (2018) 132 (Supplement 1): 3364.

https://doi.org/10.1182/blood-2018-99-113787

Published: 2018

Journal Articles

Hasford Score Is Correlated with 18 Month Molecular Response for Chronic Myeloid Leukemia Patients Treated with Second Generation Tyrosine Kinase Inhibitors and It May be Useful to Differentiate Low and Intermediate Risk Patients: A Single Institution Experience

Jaroslaw Dybko, Olga Haus, MD, Bozena Jazwiec, Tomasz Lonc, Mateusz Sawicki, Kazimierz Kuliczkowski

Blood (2015) 126 (23): 5163.

https://doi.org/10.1182/blood.V126.23.5163.5163

Published: 2015

Journal Articles

The Hasford Score Correlates with the Long-Term Molecular Response to Imatinib Treatment for Chronic Myeloid Leukemia Patients and May be Useful for Differentiating Low and Intermediate Risk Patients: A Single Institution Experience

Jaroslaw Dybko, MD PhD, Ewa Medras, MD, Olga Haus, MD PhD, Bozena Jazwiec, MSC, Tomasz Wrobel, MDPhD, Kazimierz Kuliczkowski, MD PhD Prof.

Blood (2014) 124 (21): 3152.

https://doi.org/10.1182/blood.V124.21.3152.3152

Published: 2014

Journal Articles

Conditioning Intensity Does Not Influence the Outcome of Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome. a Joint Study By the Polish Adult Leukemia Group and the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation

Blood (2014) 124 (21): 2564.

https://doi.org/10.1182/blood.V124.21.2564.2564

Published: 2014

Journal Articles

Hodgkin Lymphoma in Older Patients- a Retrospective Analysis of the Polish Lyphoma Reasearch Group

Blood (2014) 124 (21): 1737.

https://doi.org/10.1182/blood.V124.21.1737.1737

Published: 2014

Journal Articles

CD117 (c-kit) Expression On CD34+ Cells Participates In The Cytogenetic Response To Imatinib In CML Patients In First Chronic Phase

Jaroslaw Dybko, MD PhD, Ewa Medras, MD, Olga Haus, MD, PhD, Prof., Bozena Jazwiec, MSC, Joanna Urbaniak, PhD, Mieczyslaw Wozniak, PhD Prof., Kazimierz Kuliczkowski, Professor

Blood (2013) 122 (21): 3990.

https://doi.org/10.1182/blood.V122.21.3990.3990

Published: 2013

Journal Articles

Expression of PIM-2 and NF-κB Is Increased in Patients with Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) and Correlates with Complete Remission Rate

Katarzyna Kapelko-Slowik, MD, PhD, Donata Urbaniak-Kujda, MD, PhD, Dariusz Wolowiec, Jaroslaw Dybko, Bozena Jazwiec, MSC, Miroslaw Slowik, MD, PhD, Jacek Jakubaszko, MD, Tomasz Owczarek, MSC, Krzysztof Grzymajlo, MSC, Kazimierz Kuliczkowski

Blood (2011) 118 (21): 4648.

https://doi.org/10.1182/blood.V118.21.4648.4648

Published: 2011

Journal Articles

Concentrations of Metalloproteinased-9 (MMP-9), Metalloproteinases -1 and-2 Tissue Inhibitors (TIMP-1, TIMP-2), Tumor Necrosis Factor-α (TNF-α), Hepatocyte Growth Factor (HGF), Dickkopf Related Proten 1 (DKK-1) and Emmprin (CD147) Expression Are Increased in Patients with Myeloma Multiplex and MMP-9 Correlates with advanced Stage of Disease

Donata Urbaniak-Kujda, MD, PhD, Katarzyna Kapelko-Slowik, MD, PhD, Dariusz Wolowiec, Jaroslaw Dybko, Iwona Prajs, MSC, Jacek Jakubaszko, MD, Lidia Karabon, PhD, Kazimierz Kuliczkowski

Blood (2011) 118 (21): 5069.

https://doi.org/10.1182/blood.V118.21.5069.5069

Published: 2011

Journal Articles

Coexpression of Bmi-1 and Interleukin-3 Receptor Alpha Chain (CD123) Correlate with Poor Prognosis In Acute Myeloid Leukemia

Jaroslaw Dybko, Donata Urbaniak-Kujda, Katarzyna Kapelko-Slowik, Kazimierz Kuliczkowski

Blood (2010) 116 (21): 4324.

https://doi.org/10.1182/blood.V116.21.4324.4324

Published: 2010

Journal Articles

Acquired Inhibitor of Factor VIII Associated with Prostate Cancer: Case Report

Donata M. Urbaniak-Kujda, Katarzyna L. Kapelko-Slowik, Maria Podolak- Dawidziak, Kazimierz Kuliczkowski, Irena Frydecka, Jaroslaw Dybko, Dariusz Wolowiec, MD, PhD

Blood (2008) 112 (11): 4099.

https://doi.org/10.1182/blood.V112.11.4099.4099

Published: 2008

Journal Articles

Imatinib in Chronic Myeloid Leukemia - Five Years Single Center Experience.

Jaroslaw Dybko, MD, Ewa Medras, MD, Renata Bednarz, MSci, Donata Urbaniak, PhD, Kazimierz Kuliczkowski, PhD

Blood (2007) 110 (11): 4558.

https://doi.org/10.1182/blood.V110.11.4558.4558

Published: 2007

Journal Articles

CD8+CD28− in Peripheral Blood of Patients with Cutaneus T-Cell Lymphoma (CTLC) in Different Clinical Stages.

Donata M. Urbaniak-Kujda, MD, PhD, Katarzyna L. Kapelko-Slowik, MD, PhD, Bozena Jazwiec, MS, Joanna Maj, MD, PhD, Jaroslaw Dybko, MD, Miroslaw Slowik, MD, PhD, Dariusz Wolowiec, MD, PhD, Irena Frydecka, MD, PhD, Kazimierz Kuliczkowski, MD, PhD

Blood (2007) 110 (11): 4395.

https://doi.org/10.1182/blood.V110.11.4395.4395

Published: 2007

Journal Articles

Expression of the Human PIM-2 (hPIM-2) Gene in Patients with Acute Myeloblastic Leukaemia (AML) and Acute Lymphoblastic Leukaemia (ALL).

Katarzyna L. Kapelko-Slowik, MD, PhD, Donata M. Urbaniak-Kujda, MD, PhD, Bozena Jazwiec, MS, Jaroslaw Dybko, MD, Dariusz Wolowiec, MD, PhD, Miroslaw Slowik, MD, PhD, Irena Frydecka, MD, PhD, Kazimierz Kuliczkowski, MD, PhD

Blood (2007) 110 (11): 4288.

https://doi.org/10.1182/blood.V110.11.4288.4288

Published: 2007

Journal Articles

Is CD94/NKG2A a Novel Target for Lymphoid Malignancies Immunotherapy?.

Donata Urbaniak-Kujda, PhD, Jaroslaw Dybko, MD, Iwona Prajs, MSci, Marek Kielbinski, PhD, Beata Tomaszewska-Toporska, MD, Katarzyna Kapelko-Slowik, PhD, Kazimierz Kuliczkowski, PhD

Blood (2006) 108 (11): 4650.

https://doi.org/10.1182/blood.V108.11.4650.4650

Published: 2006

Journal Articles

Bmi-1 Protein Expression in CD34 Positive Acute Myelogenous Leukemia Cells as a Prognostic Factor.

Jaroslaw Dybko, MD, Bozena Jazwiec, MSci, Donata Urbaniak-Kujda, PhD, Kazimierz Kuliczkowski, PhD

Blood (2006) 108 (11): 4504.

https://doi.org/10.1182/blood.V108.11.4504.4504

Published: 2006

NARROW

Real-World Practice Patterns of Patient Management in the Peri-CAR T-Cell Therapy Setting for Patients with Mantle Cell Lymphoma: An International Survey on Behalf of the EBMT Lymphoma Working Party

Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study

Analysis of Risk Factors Determining Incidence and Outcome of Infections in Children and Adults after Hematopoietic Cell Transplantation

Hasford Score Is Correlated with 18 Month Molecular Response for Chronic Myeloid Leukemia Patients Treated with Second Generation Tyrosine Kinase Inhibitors and It May be Useful to Differentiate Low and Intermediate Risk Patients: A Single Institution Experience

The Hasford Score Correlates with the Long-Term Molecular Response to Imatinib Treatment for Chronic Myeloid Leukemia Patients and May be Useful for Differentiating Low and Intermediate Risk Patients: A Single Institution Experience

Conditioning Intensity Does Not Influence the Outcome of Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome. a Joint Study By the Polish Adult Leukemia Group and the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation

Hodgkin Lymphoma in Older Patients- a Retrospective Analysis of the Polish Lyphoma Reasearch Group

CD117 (c-kit) Expression On CD34+ Cells Participates In The Cytogenetic Response To Imatinib In CML Patients In First Chronic Phase

Expression of PIM-2 and NF-κB Is Increased in Patients with Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) and Correlates with Complete Remission Rate

Coexpression of Bmi-1 and Interleukin-3 Receptor Alpha Chain (CD123) Correlate with Poor Prognosis In Acute Myeloid Leukemia

Acquired Inhibitor of Factor VIII Associated with Prostate Cancer: Case Report

Imatinib in Chronic Myeloid Leukemia - Five Years Single Center Experience.

CD8+CD28− in Peripheral Blood of Patients with Cutaneus T-Cell Lymphoma (CTLC) in Different Clinical Stages.

Expression of the Human PIM-2 (hPIM-2) Gene in Patients with Acute Myeloblastic Leukaemia (AML) and Acute Lymphoblastic Leukaemia (ALL).

Is CD94/NKG2A a Novel Target for Lymphoid Malignancies Immunotherapy?.

Bmi-1 Protein Expression in CD34 Positive Acute Myelogenous Leukemia Cells as a Prognostic Factor.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only